ConductScience.org, home

Paper10694562

Long-term prognosis after resection of hepatocellular carcinoma associated with hepatitis B-related cirrhosis.

Poon RT and 5 others. J Clin Oncol, 2000. Cited by 164 papers, by iCite.

Cite this record

ConductScience Library. Long-term prognosis after resection of hepatocellular carcinoma associated with hepatitis B-related cirrhosis. Papers, record 10694562. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/10694562

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Long-term prognosis after resection of hepatocellular carcinoma associated with hepatitis B-related cirrhosis.
PubMed
Journal
J Clin Oncol
PubMed
Year
2000
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
164
iCite
Relative citation ratio, by iCite
4.31
iCite
Revised in PubMed
2022-03-18
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Poon RTR T
2Fan STS T
3Lo CMC M
4Liu CLC L
5Ng IOI O
6Wong JJ

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Carcinoma, HepatocellularMajor topic
Hepatitis BMajor topic
Liver CirrhosisMajor topic
Liver NeoplasmsMajor topic
Disease-Free Survival
Female
Humans
Male
Middle Aged
Prognosis
Prospective Studies
Survival Analysis

Source PubMed

Download CSV of topics

Cited by58

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 164 citations.

PMIDTitleJournalYearIn PapersSource
42568414Liver resection is associated with better survival than TACE for hepatocellular carcinoma modestly beyond Milan criteria: a multicenter propensity-matched analysis.Front Oncol2026https://conductscience.org/library/papers/42568414PubMed
41484570Adjuvant anlotinib plus TACE in hepatocellular carcinoma with postoperative high-risk recurrence: a single-arm, multi-center, phase II study.Clin Transl Oncol2026https://conductscience.org/library/papers/41484570PubMed
40796708Laparoscopic versus open repeat liver resection for recurrent liver cancer: an updated systematic review and meta-analysis.Updates Surg2025https://conductscience.org/library/papers/40796708PubMed
36050540Vessels that encapsulate tumor clusters (VETC) pattern predicts the efficacy of adjuvant TACE in hepatocellular carcinoma.J Cancer Res Clin Oncol2023https://conductscience.org/library/papers/36050540PubMed
35734623Laparoscopic vs open liver re-resection for cirrhotic patients with post-hepatectomy hepatocellular carcinoma recurrence: A comparative study.World J Gastrointest Surg2022https://conductscience.org/library/papers/35734623PubMed
35723760The efficacy of transarterial chemoembolization in downstaging unresectable hepatocellular carcinoma to curative therapy: a predicted regression model.Invest New Drugs2022https://conductscience.org/library/papers/35723760PubMed
35211422The AST/ALT Ratio (De Ritis Ratio) Represents an Unfavorable Prognosis in Patients in Early-Stage SFTS: An Observational Cohort Study.Front Cell Infect Microbiol2022https://conductscience.org/library/papers/35211422PubMed
34539896Preoperative Versus Postoperative Transarterial Chemoembolization on Prognosis of Large Hepatocellular Carcinoma.J Cancer2021https://conductscience.org/library/papers/34539896PubMed
34430571Nomogram for predicting pathologic complete response after transarterial chemoembolization in patients with hepatocellular carcinoma.Ann Transl Med2021https://conductscience.org/library/papers/34430571PubMed
33996606Efficacy of Liver Resection for Single Large Hepatocellular Carcinoma in Child-Pugh A Cirrhosis: Analysis of a Nationwide Cancer Registry Database.Front Oncol2021https://conductscience.org/library/papers/33996606PubMed
33725402A Transcriptomic Signature for Risk-Stratification and Recurrence Prediction in Intrahepatic Cholangiocarcinoma.Hepatology2021https://conductscience.org/library/papers/33725402PubMed
33442451Comparison between hepatocellular carcinoma prognostic scores: A 10-year single-center experience and brief review of the current literature.World J Hepatol2020https://conductscience.org/library/papers/33442451PubMed
33394207Predictors of five-year survival among patients with hepatocellular carcinoma in the United States: an analysis of SEER-Medicare.Cancer Causes Control2021https://conductscience.org/library/papers/33394207PubMed
33234055The Prognostic Value of Circulating VEGF-A Level in Patients With Hepatocellular Cancer.Technol Cancer Res Treat2020https://conductscience.org/library/papers/33234055PubMed
33003646Circulatory miRNA as a Biomarker for Therapy Response and Disease-Free Survival in Hepatocellular Carcinoma.Cancers (Basel)2020https://conductscience.org/library/papers/33003646PubMed
32368139
Long-Term Survival in Patients Receiving Combination Therapy with Resection and Radiofrequency Ablation for Multi-Focal Hepatocellular Carcinoma Classified as Barcelona Clinic Liver Cancer Stage B: A Retrospective Controlled Study.
Cancer Manag Res2020https://conductscience.org/library/papers/32368139PubMed
31674731Low expression of long noncoding RNA CTC-297N7.9 predicts poor prognosis in patients with hepatocellular carcinoma.Cancer Med2019https://conductscience.org/library/papers/31674731PubMed
31342257Comparison of clinical outcomes of laparoscopic versus open surgery for recurrent hepatocellular carcinoma: a meta-analysis.Surg Endosc2019https://conductscience.org/library/papers/31342257PubMed
31136302Beneficial effects of Cripto-1 for transarterial chemoembolization in hepatocellular carcinoma.Aging (Albany NY)2019https://conductscience.org/library/papers/31136302PubMed
31020447Inflammation-nutrition score predicts prognosis of patients with resectable hepatocellular carcinoma.Int J Clin Oncol2019https://conductscience.org/library/papers/31020447PubMed

See all 58 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/10694562

GET https://conductscience.org/api/papers/v1/10694562/cited_by?page=2